Literature DB >> 33645531

Structure and comparison of the motor domain of centromere-associated protein E.

Asuka Shibuya1, Naohisa Ogo2, Jun Ichi Sawada2, Akira Asai2, Hideshi Yokoyama1.   

Abstract

Centromere-associated protein E (CENP-E) plays an essential role in mitosis and is a target candidate for anticancer drugs. However, it is difficult to design small-molecule inhibitors of CENP-E kinesin motor ATPase activity owing to a lack of structural information on the CENP-E motor domain in complex with its inhibitors. Here, the CENP-E motor domain was crystallized in the presence of an ATP-competitive inhibitor and the crystal structure was determined at 1.9 Å resolution. In the determined structure, ADP was observed instead of the inhibitor in the nucleotide-binding site, even though no ADP was added during protein preparation. Structural comparison with the structures of previously reported CENP-E and those of other kinesins indicates that the determined structure is nearly identical except for several loop regions. However, the retention of ADP in the nucleotide-binding site of the structure strengthens the biochemical view that the release of ADP is a rate-limiting step in the ATPase cycle of CENP-E. These results will contribute to the development of anticancer drugs targeting CENP-E and to understanding the function of kinesin motor domains. open access.

Entities:  

Keywords:  CENP-E; anticancer drugs; kinesins

Year:  2021        PMID: 33645531      PMCID: PMC7919405          DOI: 10.1107/S2059798321000176

Source DB:  PubMed          Journal:  Acta Crystallogr D Struct Biol        ISSN: 2059-7983            Impact factor:   7.652


  29 in total

1.  Crystal structure of the mitotic spindle kinesin Eg5 reveals a novel conformation of the neck-linker.

Authors:  J Turner; R Anderson; J Guo; C Beraud; R Fletterick; R Sakowicz
Journal:  J Biol Chem       Date:  2001-04-27       Impact factor: 5.157

2.  CENP-E is essential for reliable bioriented spindle attachment, but chromosome alignment can be achieved via redundant mechanisms in mammalian cells.

Authors:  B F McEwen; G K Chan; B Zubrowski; M S Savoian; M T Sauer; T J Yen
Journal:  Mol Biol Cell       Date:  2001-09       Impact factor: 4.138

3.  Bis(hetero)aryl derivatives as unique kinesin spindle protein inhibitors.

Authors:  Kenji Matsuno; Jun-ichi Sawada; Mina Sugimoto; Naohisa Ogo; Akira Asai
Journal:  Bioorg Med Chem Lett       Date:  2009-01-11       Impact factor: 2.823

4.  Loop L5 assumes three distinct orientations during the ATPase cycle of the mitotic kinesin Eg5: a transient and time-resolved fluorescence study.

Authors:  Joseph M Muretta; William M Behnke-Parks; Jennifer Major; Karl J Petersen; Adeline Goulet; Carolyn A Moores; David D Thomas; Steven S Rosenfeld
Journal:  J Biol Chem       Date:  2013-10-21       Impact factor: 5.157

5.  ATP hydrolysis in Eg5 kinesin involves a catalytic two-water mechanism.

Authors:  Courtney L Parke; Edward J Wojcik; Sunyoung Kim; David K Worthylake
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

6.  Microtubule capture by mitotic kinesin centromere protein E (CENP-E).

Authors:  Harjinder S Sardar; Susan P Gilbert
Journal:  J Biol Chem       Date:  2012-05-27       Impact factor: 5.157

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  Antitumor activity of a kinesin inhibitor.

Authors:  Roman Sakowicz; Jeffrey T Finer; Christophe Beraud; Anne Crompton; Evan Lewis; Alex Fritsch; Yan Lee; John Mak; Robert Moody; Rebecca Turincio; John C Chabala; Paul Gonzales; Stephanie Roth; Steve Weitman; Kenneth W Wood
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

9.  Structural and Thermodynamic Basis of the Enhanced Interaction between Kinesin Spindle Protein Eg5 and STLC-type Inhibitors.

Authors:  Hideshi Yokoyama; Jun-Ichi Sawada; Kohei Sato; Naohisa Ogo; Nanami Kamei; Yoshinobu Ishikawa; Kodai Hara; Akira Asai; Hiroshi Hashimoto
Journal:  ACS Omega       Date:  2018-09-28

Review 10.  Recent findings and future directions for interpolar mitotic kinesin inhibitors in cancer therapy.

Authors:  Stephanie M Myers; Ian Collins
Journal:  Future Med Chem       Date:  2016-03-15       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.